Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Blood|January 18, 2024
T-cell dysfunctions in myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Simona Colla
Seminars in Hematology|October 18, 2024
Inflammation in myelodysplastic syndrome pathogenesisJuan Jose Rodriguez-Sevilla, Simona Colla
Genes|September 23, 2022
Causes and Pathophysiology of Acquired Sideroblastic AnemiaJuan Jose Rodriguez-Sevilla, Xavier Calvo, Leonor Arenillas
Frontiers in Medicine|May 2, 2022
Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?Juan Jose Rodriguez-Sevilla, Roberto Güerri-Fernádez, Bernat Bertran Recasens
Cell Reports. Medicine|February 14, 2023
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translationJuan Jose Rodriguez-Sevilla, Vera Adema, Guillermo Garcia-Manero, et al.
Leukemia & Lymphoma|May 7, 2024
Advances in the management of higher-risk myelodysplastic syndromes: future prospectsGeorgina Gener-Ricos, Juan Jose Rodriguez-Sevilla, Samuel Urrutia, et al.
Virchows Archiv : an International Journal of Pathology|July 5, 2022
PCM1::JAK2 fusion associates with an atypical form of mycosis fungoidesJuan Jose Rodriguez-Sevilla, Marta Salido, Maria Rodriguez-Rivera, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Hematology (Amsterdam, Netherlands)|September 22, 2021
Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomasMartí Mascaró-Pol, Ramón Díez-Feijoo, Juan Jose Rodriguez-Sevilla, et al.
Blood Advances|June 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuumXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
Pageof 3